dGNaC1, a Gonad-specific Amiloride-sensitive Na+ Channel*

Isabelle DarbouxDagger , Eric Lingueglia, Guy Champigny, Sylvie Coscoy§, Pascal Barbry, and Michel Lazdunski

From the Institut de Pharmacologie Moléculaire et Cellulaire, CNRS UPR 411, 660 route des Lucioles, Sophia Antipolis, 06560 Valbonne, France

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Amiloride-sensitive sodium channels have been implicated in reproductive and early developmental processes of several species. These include the fast block of polyspermy in Xenopus oocytes that follows the sperm binding to the egg or blastocoel expansion in mammalian embryo. We have now identified a gene called dGNaC1 that is specifically expressed in the gonads and early embryo in Drosophila melanogaster. The corresponding protein belongs to the superfamily of cationic channels blocked by amiloride that includes Caenorhabditis elegans degenerins, the Helix aspersa FMRF-amide ionotropic receptor (FaNaC), the mammalian epithelial Na+ channel (ENaC), and acid-sensing ionic channels (ASIC, DRASIC, and MDEG). Expression of dGNaC1 in Xenopus oocytes generates a constitutive current that does not discriminate between Na+ and Li+, but is selective for Na+ over K+. This current is blocked by amiloride (IC50 = 24 µM), benzamil (IC50 = 2 µM), and ethylisopropyl amiloride (IC50 = 49 µM). These properties are clearly different from those obtained after expression of the previously cloned members of this family, including ENaC and the human alpha ENaC-like subunit, delta NaC. Interestingly, the pharmacology of dGNaC1 is not very different from that found for the Na+ channel characterized in rabbit preimplantation embryos. We postulate that this channel may participate in gametogenesis and early embryonic development in Drosophila.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The importance of amiloride-sensitive sodium transport during reproductive and early developmental processes is highlighted by numerous experiments performed in diverse organisms, such as sea urchins (1, 2), fish (3), amphibians (4-6), and mammals (7). Amiloride interacts not only with ubiquitous Na+/H+ antiporters, which are also expressed in gonads and are involved in initiation of development at fertilization (8), but also with amiloride-blockable channels that are involved in the fast block of polyspermy (9) and blastocoel expansion (10). In Xenopus oocytes, ATP triggers an amiloride-sensitive Na+ channel immediately after the sperm has bound to the egg. This depolarizes the egg membrane potential and participates in the fast block of polyspermy (9). In mammalian embryo, amiloride-sensitive sodium channels are also involved in the blastocoel expansion (11). During early phases of animal embryonic development, blastomeres progressively occupy the periphery of the embryo, and a fluid-filled central cavity, i.e. the blastocoel, is formed. Fluid accumulation in the blastocoel is due to an electrogenic transport of sodium, followed by osmotically driven water, and this event can be partly inhibited by amiloride (10, 12, 13). Electrophysiological analyses have demonstrated that amiloride-sensitive channels are expressed in rabbit blastomeres, but their biophysical and pharmacological properties differ from those of the classical highly Na+-selective and highly amiloride-inhibitable channel (10).

Amiloride sensitivity is a common characteristic of structurally related cationic channels that are associated with a wide range of distinct physiological functions (14). In Caenorhabditis elegans, neuronal and muscular degenerins, such as MEC-4, MEC-10, UNC-8, and UNC-105, encode amiloride-sensitive channels that are involved in mechanoperception (15-17). In animal epithelia, a highly sodium-selective channel is made up of three homologous subunits (alpha ENaC (epithelial Na+ channel), beta ENaC, and gamma ENaC) (18-21). This channel participates in active vectorial sodium transport. In the snail nervous system, FaNaC is an ionotropic receptor for the mollusc cardioexcitatory peptide FMRF-amide. It forms a homotetrameric sodium-selective channel that may be involved in neuromodulation (22, 23). In mammalian brain and/or in sensory neurons, acid-sensing ionic channels (ASIC) are homo- or heteromultimeric H+-activated cation channels (24-27). They are suspected to be involved in nociception linked to acidosis. All these proteins share the same structural organization, characterized by the presence of two hydrophobic domains surrounding a large extracellular loop that includes one cysteine-rich region (or two for degenerins) (28). Despite a very low identity between the most distantly related proteins of the family (~15%), some important residues, such as those located in pre-M1, pre-M2, and M2 regions (where M1 and M2 represent the two transmembrane hydrophobic alpha -helices), are conserved.

Different members of this family have been described in mammalian gonads or in adjacent tissues. Expressed sequence tags of alpha ENaC, delta NaC (Na+ channel delta subunit; an alpha ENaC-like subunit) (29), and ASIC-1 have been identified in human testis. Only human delta NaC was indeed detected in testis and ovary by Northern blot analysis (29). This raises the possibility that members of the degenerin/ENaC/FaNaC/ASIC gene superfamily might be involved in the differentiation of gametes and/or development of eggs after fertilization.

In this study, we have characterized a new member of the family in D. melanogaster, which is specifically expressed in testis, ovary, and early embryo. Its expression in Xenopus oocytes was sufficient to generate a constitutive amiloride-sensitive Na+ channel, with properties that differ from those obtained after expression of alpha beta gamma ENaC or delta NaC/beta gamma ENaC. Since this Drosophila Na+-selective channel is specifically expressed in the gonads and early embryo, we postulate that it may correspond to a channel involved in spermatogenesis, oogenesis, and/or early embryonic development.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cloning of dGNaC1-- Two sequences from the Drosophila expressed sequence tag data base (accession numbers AA264333 and AA264288) were used to design a sense and an antisense primer carrying an EcoRI (sense primer) and an XhoI (antisense primer) restriction site, respectively, at their 5'-ends. The corresponding sequences are as follows: 5'-ACGAATTCAAGAACGGAATAGACACCATG-3' and 5'-TCCTCGAGTTGTCCGCACTTACGAAATAG-3'. These primers were used to amplify a 1750-base pair fragment by PCR1 with the Expand High Fidelity PCR system (Boehringer Mannheim) from Drosophila cDNAs prepared from mid-stage embryos. After methylation of the internal EcoRI restriction site with EcoRI methylase (Biolabs), ligation of EcoRI linkers (Biolabs), and digestion by EcoRI and XhoI, the fragment was subcloned in the EcoRI and XhoI sites of the pBSK-SP6-globin vector (30). Three independent clones were sequenced on both strands. They display an open reading frame of 1686 nucleotides that is not preceded by stop codon.

Fly Stocks-- All fly stocks (Oregon R or w1118) were maintained under standard culture conditions.

In Situ Chromosomal Mapping-- For in situ hybridization to polytene salivary gland chromosomes, the pBSK-SP6-globin vector containing the entire cDNA sequence of dGNaC1 was labeled with biotin-11-dUTP (Boehringer Mannheim) by random priming according to the manufacturer's instructions.

Expression in Oocytes and Electrophysiological Analysis-- For expression in Xenopus oocytes, cRNA was synthesized from the NotI-digested vector using a kit from Stratagene. Xenopus oocytes were injected with 0.5-5 ng of cRNA, and microelectrode voltage-clamp assays were performed 1-5 days after injection.

Northern Blotting and RT-PCR-- Total RNA was obtained from staged embryos, larvae, pupae, and adults by the acidic phenol method (31). Five micrograms of total RNA from each developmental stage were fractionated by electrophoresis on a formaldehyde-containing 0.8% agarose gel and transferred to Nylon membrane (Hybond N, Amersham Pharmacia Biotech). The entire coding sequence of dGNaC1 was radiolabeled by the random priming method (Promega) and used as a probe (106 cpm/ml) for overnight hybridization at 42 °C in a solution containing 30% formamide, 5× Denhardt's solution, 5× SSC, 0.1% SDS, and 100 µg/ml denatured salmon sperm DNA. After washing in 0.2× SSC and 0.1% SDS at 55 °C, the blot was exposed to Kodak X-Omat AR film for 14 days at -70 °C with intensifying screens. The filter was subsequently hybridized with a probe encoding the Drosophila rpl17 gene (32) to estimate the relative amount of RNA loaded in each lane.

For RT-PCR experiments, total RNAs were treated with RNase-free DNase I (Boehringer Mannheim) to remove contaminating genomic DNA. For first strand cDNA synthesis, 2 µg of total RNA were oligo(dT)-primed in a final volume of 20 µl in the presence or absence of 200 units of Superscript II reverse transcriptase (Life Technologies, Inc.). The reaction was carried out at 42 °C for 1 h and heated at 70 °C for 15 min. For the PCR analysis, 2 µl of RT products were used with 1 unit of Taq DNA polymerase (Promega) and 200 ng of the sense primer (the same as described previously for dGNaC1 cloning) and the antisense primer (5'-TCCTCGAGTGAACTGGCTGTAAAGATCAG-3') in a 20-µl reaction mixture. Forty cycles of PCR (94 °C for 1 min, 60 °C for 1 min, and 72 °C for 1 min) were performed, except for the rpl17-specific primers, for which only 20 cycles were performed. PCR products were gel electrophoresed and visualized by ethidium bromide staining.

In Situ Hybridization-- Whole-mount in situ hybridization of embryos and egg chambers was carried out according to Tautz and Pfeifle (33). Digoxigenin-labeled RNA probes corresponding to the whole coding sequence were synthesized according to the manufacturer's instructions (Promega, Riboprobe, Gemini II-Core system). Ovaries and testes were dissected in phosphate-buffered saline and transferred directly to the fix solution consisting of 4% paraformaldehyde in phosphate-buffered saline. After washing in phosphate-buffered saline and 0.1% Tween 20, tissues were treated with proteinase K (50 µg/ml for 5 min). RNA probes were hybridized overnight at 55 °C in 25% formamide, 2× SSC, 100 µg/ml salmon sperm DNA, 50 µg/ml heparin, and 0.1% Tween 20. Tissues were mounted in 80% glycerol and viewed with a microscope under Nomarski optics.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Cloning and Structure of dGNaC1-- Two partial cDNA sequences from Drosophila embryo similar to those of other members of the degenerin/ENaC/FaNaC/ASIC superfamily were found in the data base of expressed sequence tags (accession numbers AA264333 and AA264288). One displayed similarity in the 5'-coding region (AA264333), including the first transmembrane domain, and contained a putative start codon. The other (AA264288) showed similarity in the 3'-coding region, including the second transmembrane domain, and contained a putative stop codon. Two oligonucleotides flanking the putative coding sequence were used to amplify by PCR a fragment of 1750 base pairs from Drosophila cDNA. It contains an open reading frame of 1686 base pairs and codes for a protein of 562 amino acids (Fig. 1A). This protein has all the hallmarks of the degenerin/ENaC/FaNaC/ASIC superfamily, i.e. two hydrophobic domains flanking a large region including a cysteine-rich domain (Fig. 1, A and B) that was shown to be extracellular for the epithelial Na+ channel (34) and for the degenerin MEC-4 (35). dGNaC1 was mapped by in situ hybridization to region 82CD on the right arm of the third chromosome (data not shown).


View larger version (94K):
[in this window]
[in a new window]
 
Fig. 1.   Protein sequence of dGNaC1 and comparison with other members of the degenerin/ENaC/FaNaC/ASIC family. A, sequence comparison between dGNaC1 and human alpha ENaC. The two putative transmembrane regions M1 (M I) and M2 (M II) are indicated by thick lines above the sequence. External cysteines are marked with asterisks. Identical and similar residues are printed white on black and black on gray, respectively. B, schematic presentation of structural homologies. CRD, cysteine-rich domain. C, protein identity between dGNaC1 and other members of the family. The sequences were aligned using the GCG Pileup program, with minor manual corrections when necessary, and identities were calculated with the GCG Distances program without correction for multiple substitutions. Accession numbers for human alpha ENaC, delta NaC, ASIC, FaNaC, and MEC-4 are X76180, U38254, U94403, X92113, and U53669, respectively.

Expression of dGNaC1 in Xenopus Oocytes-- When dGNaC1 cRNA was injected into Xenopus oocytes, an amiloride-sensitive Na+-selective current was recorded (Fig. 2A). Large variations in the amplitude of the amiloride-sensitive current were found in different oocyte batches (from a few tens of nA up to ~1 µA). Treatment with ATP, a jump in the external pH, and activation of protein kinases A and C were not able to alter the current (data not shown). The ionic substitutions experiments (Fig. 2C) and the inversion of the amiloride-sensitive current at positive potential values (Er = 36.5 ± 6.6 mV, n = 11) (Fig. 2D) suggested a higher permeability of the channel for Na+ over K+ and an equal permeability for Li+ and Na+. Amiloride and its derivative, ethylisopropyl amiloride, blocked the channel, with half-inhibition concentrations (IC50) of 24 and 49 µM, respectively, whereas benzamil was found to be more effective, with an IC50 of 2 µM (Fig. 2B).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2.   Expression of dGNaC1 in Xenopus oocytes. A, effect of amiloride (Ami) on the current recorded on a whole oocyte at -70 mV. B, sensitivity of the current recorded at -70 mV to amiloride and its derivatives. Each point represents mean values from five oocytes. C, effect of substituting Na+ for Li+ or K+ in the external medium on the amiloride-sensitive current recorded at -70 mV. Results are from seven different oocytes. D, I-V relationship of the amiloride-sensitive current (1 mM amiloride) obtained by a voltage ramp from -150 to 100 mV in Na+-containing medium. The reversal potential was close to 40 mV. EIPA, ethylisopropyl amiloride.

Expression of dGNaC1 during Development-- The expression pattern of dGNaC1 was analyzed by Northern blot hybridization of total RNA isolated from different developmental stages (Fig. 3A). Three observations were made. First, two forms of mRNA are transcribed: one major RNA transcript of 3.2 kb and a second transcript of 2.3 kb, probably explained by different mRNA polyadenylation, alternative splicing of the dGNaC1 gene, or the presence of a closely related homologous mRNA. Second, the expression level is strongly regulated during development (Fig. 3A). The mRNA was readily detected in early embryos (0-4 h), suggesting a high level of maternal expression. However, no further expression was detected during late embryogenesis. Third, dGNaC1 is specifically transcribed in the gonads (Fig. 3, A and B). The highest RNA level was detected in ovaries; RNA was still detectable in whole females, but not in females lacking ovaries or in males (Fig. 3A). More sensitive measurements made using RT-PCR detected dGNaC1 transcripts in whole males due to specific expression in the genital tract (Fig. 3B). No signal was observed in males after removal of their genital tracts or in females after removal of their ovaries (Fig. 3B).


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 3.   A, Northern blot of total RNA showing the developmental expression of dGNaC1. Total RNA was prepared from Drosophila at various stages of development. Hybridization was carried out using the entire dGNaC1 cDNA as a probe. Lanes are marked according to the specific developmental stage; numbers during embryonic stages refer to hours of development after fertilization. L3, third larval stage; P, pupal stage. The blot shows an abundant transcript of 3.2 kb and a less abundant one of 2.3 kb in early embryos (0-4 h). These transcripts are also abundant in ovaries, but occur at much lower levels in whole females. The amount of RNA loaded in each lane was estimated by rehybridization with a cDNA probe coding for the ribosomal protein L17A (rpl17; bottom panels). Sizes (in kb) are indicated on the left. B, RT-PCR analysis of dGNaC1 gene expression in male and female gonads. Ovaries and male genital tracts were dissected from remaining tissues (carcasses), and RNAs were prepared as described under "Experimental Procedures." Expression of the gene encoding ribosomal protein rpl17 served as a control. + and -, with and without reverse transcriptase, respectively.

A more precise determination of dGNaC1 transcript localization was assessed by in situ hybridization. Experiments with digoxigenin-labeled antisense RNA probes and control experiments with sense probes were performed on wild-type ovaries and testes (Fig. 4). dGNaC1 RNA was not detectable in ovarian stem cells, oogonia, and early cysts (Fig. 4A). They were weakly detected at stage 5 (according to the criteria of King (36)), and the highest expression was seen at stage 10, where they were present throughout the nurse cells, oocytes, and follicle cells (Fig. 4, A and B). In situ hybridization was also performed on whole-mount embryos. The criteria of Campos-Ortega and Hartenstein (37) were used to identify stages of embryonic development. At the syncytial stage (stage 4), prior to cellularization, dGNaC1 was distributed uniformly within the cytoplasm (Fig. 4C). It was also detected in the cellular blastoderm embryo (Fig. 4D). The pole cells, the progenitors of the germ line, did not accumulate dGNaC1 transcripts (Fig. 4D). Levels of transcript then declined in embryos at stage 8, i.e. at early gastrulation (Fig. 4E), and subsequently vanished.


View larger version (122K):
[in this window]
[in a new window]
 
Fig. 4.   In situ hybridization with a digoxigenin-labeled dGNaC1 antisense RNA probe to adult gonads and early embryos. In wild-type ovarioles (A), weak staining appears in stage 5 and continues to accumulate both in nurse cells and in the oocyte at stage 10. They are also detectable in the follicle cell monolayer that surrounds the oocyte at stage 11 (B). High levels of dGNaC1 transcripts are present throughout the syncytial embryos both prior to pole cell formation (C) and following pole cell formation, in the early blastoderm stage (D). No dGNaC1 transcripts are detected in pole cells (D, arrowhead). During germ band extension, dGNaC1 is expressed in the presumptive mesoderm (E). Expression is not detected afterward. Dorsal is up and anterior is to the left. Expression of dGNaC1 in the adult male reproductive tract is shown (G). dGNaC1 RNAs are detected in testis, except at the apical region of the testis (ap.), and in the seminal vesicle (sem. ves.). No labeling is detected in the early embryo (F) or in the ovariole and male reproductive tract (not shown) with a dGNaC1 sense RNA probe.

In situ hybridization on the male genital tract also revealed the presence of transcript. dGNaC1 was not detected in the apical tips, which contain the stem cells and gonial cysts, but it was detected in the cysts that contain primary spermatocytes or cells entering meiosis (Fig. 4G). dGNaC1 was also detected in seminal vesicles (Fig. 4G).

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

This work reports the identification of a gene related to the degenerin/ENaC/FaNaC/ASIC superfamily of ion channels in D. melanogaster. This finding is consistent with the view that amiloride-sensitive Na+ channels are widely expressed throughout the whole animal kingdom. Physiological studies have previously shown that a channel related to the epithelial sodium channel is present in the leech Hirudo medicinalis, where it controls animal volume (38), and in Lumbricus terrestris intestine, where amiloride-sensitive sodium transport displays seasonal changes via an unknown hormonal regulatory mechanism (39). Moreover, the C. elegans degenerins are widely expressed in nematode neurons and muscle (40), and Helix or Aplysia neurons express the FMRF-amide ionotropic receptor (22).

The Drosophila gene encodes dGNaC1, a protein of 562 amino acids that contains all the conserved motifs characteristic of the family. This protein has significant but low sequence identity to the other members of the family (below 20%) (Fig. 1C) and cannot be linked to any of them by phylogenetic analyses (data not shown), except for another protein identified in Drosophila peripheral nervous system that displays 38% identity to dGNaC1 (41, 53). Similarity was stronger around the first and second transmembrane domains, but was low in the large extracellular loop, except for the cysteine-rich region and the two highly conserved motifs 107FPAVTVC113 and 224GICYTFN230 (Fig. 1A). Despite distant phylogenetic relationships, the overall structure of dGNaC1 makes it closer to alpha ENaC, beta ENaC, gamma ENaC, or delta NaC than to the other members of the family (Fig. 1B). According to the classification proposed by Barbry and Hofman (28), dGNaC1 would therefore group with the proteins involved in vectorial transport, in agreement with the functional properties of the dGNaC1 channel recorded in Xenopus oocytes (Fig. 2). It should be noted that the intracellular COOH-terminal part of dGNaC1, which was shown to have an important role in epithelial sodium channel regulation (42-44), is extremely short.

The channel expressed in Xenopus oocytes after injection of the in vitro transcribed RNA is highly selective for Na+ over K+ and is blocked by amiloride. While ENaC is more permeant to Li+ than to Na+, dGNaC1 does not discriminate between Na+ and Li+ and displays a small but significant K+ permeability. Amiloride concentrations needed to block this channel are 10-100 times higher than those necessary to block ENaC or delta NaC (20, 29). Ethylisopropyl amiloride, a classical high affinity blocker of the Na+/H+ antiporter, can also efficiently block the dGNaC1 channel, with a potency similar to that of amiloride. Ethylisopropyl amiloride is much less active than amiloride in blocking the ENaC channel (20). The dGNaC1 single-channel conductance was difficult to assess due to a noisy current with no resolved unitary current levels (data not shown). The pharmacological and biophysical properties of dGNaC1 are very close to those of an alpha beta gamma ENaC channel comprising a mutated alpha -subunit in which Ser589 in the second transmembrane domain was changed to a phenylalanine (30), i.e. the residue found in the equivalent position of dGNaC1.

Successful heterologous expression of dGNaC1 was obtained only in Xenopus oocytes. It was actually not possible to record any dGNaC1 activity in transfected mammalian COS cells (data not shown). This strongly suggests that dGNaC1 channel activity is modulated by a Xenopus oocyte-specific factor. This is particularly noteworthy since expression of dGNaC1 transcripts in Drosophila was also restricted to oocytes of late vitellogenic stages and to early embryos, in addition to nurse cells and follicular cells. Transcripts disappeared completely at the stage of late gastrulation. Thus, dGNaC1 corresponds to a maternally encoded gene.

The functional properties of dGNaC1 described here can presently be related to two distinct physiological processes. First, between stages 10 and 14, the oocyte develops in an egg chamber comprising a cyst of 15 nurse cells interconnected by ring canals at the anterior edge. The single oocyte is surrounded with an epithelium layer of follicle cells (for review, see Ref. 45). Active transcription and translation by nurse cells produce the different constituents that are necessary for efficient growth of the oocyte. They are coupled to transport from nurse cells to the oocyte through intercellular junctions. Voltage gradients between nurse cells and the oocyte were first reported and proposed to explain this transport by Woodruff and Telfer (46). However, available evidence does not support a role for electrophoresis in the early phases of transport (47). Using a vibrating probe, Overall and Jaffé (48) have described a large steady Na+ influx through the anterior or nurse cell end of the follicles. Coupled with efflux at the posterior side of the egg, this transcellular transport is expected to be coupled to osmotic transport of water. The drag effect that can accompany this active Na+ transport would in that case carry macromolecules. dGNaC1 transcripts were found in nurse cells and follicular cells. This raises the possibility that dGNaC1 is involved in the entry of sodium into nurse cells. A second potential role for dGNaC1 could be in the hydration event that is associated with ovulation in Drosophila (49) and more generally in the large swelling of the oocytes that is observed during final maturation. Interestingly, LaFleur and Thomas (3) have reported that in marine teleosts, such oocyte swelling is partially blocked by amiloride (3).

A similar dGNaC1 function related to volume increase could take place in testis, where dGNaC1 transcripts are detected in the primary spermatocyte stage of development and in later cells in the spermiogenic pathway. The primary spermatocyte transcribes most if not all of the gene products needed for the dramatic morphogenetic events that follow meiosis (for review, see Fuller (50)). The primary spermatocyte stage lasts 90 h. During this time, the cells grow 25 times in volume (51). Such volume increase may be related to electrogenic sodium transport through dGNaC1, osmotically followed by water. Nevertheless, since there exist mechanisms that act during spermatogenesis to delay translation of certain messages until well after transcription, a function later in spermiogenesis cannot be excluded.

Amiloride-sensitive Na+ channels have been implicated in vertebrate development. In mammalian embryo, the blastocoel is formed by fluid accumulation due to an electrogenic transport of sodium partly inhibited by amiloride (10, 12, 13). In Drosophila, a stage 5 embryo, which corresponds to mammalian blastula, is indeed a syncytium lacking a fluid-filled central cavity (for review, see Foe et al. (52)). Thus, dGNaC1 can hardly be linked to blastocoelic expansion. Nevertheless, the Na+ channel characterized in 7-day postcoitus preimplantation embryos in rabbits is inhibited by amiloride, benzamil, and ethylisopropyl amiloride, with apparent dissociation constants of 12, 50, and 16 µM, respectively (10). These values are not very different from those found for dGNaC1, but they are clearly distinct from those found for the classical epithelial Na+ channel (28) or for the human sodium channel delta -subunit (29). One can thus infer from the gonad-specific expression of dGNaC1 in Drosophila that new members of the degenerin/ENaC/FaNaC/ASIC gene superfamily similar to dGNaC1 will be identified in vertebrate gonads, where they will be involved in early developmental processes.

In conclusion, we report here the properties of dGNaC1, a new gonad-specific Drosophila amiloride-sensitive Na+ channel that may participate in gametogenesis and early embryonic development. Elucidation of the regulatory properties of this channel will probably reveal important mechanisms controlling early steps of development.

    ACKNOWLEDGEMENTS

We are very grateful to Drs. Hideki Sakai, David Pauron, Pierre Leopold, and Michel Semeriva for fruitful discussions. We thank Dr. Amanda Patel for careful reading of the manuscript. Thanks are due to Franck Aguila for help with the artwork and to Valérie Friend, Martine Jodar, Nathalie Leroudier, and Dahvya Doume for technical assistance. We thank the Laboratoire de Génétique et Physiologie du Développement (UMR 9943 CNRS-Université) for technical facilities.

    Note Added in Proof

dGNaC1 is identical to the Ripped Pocket (RPK) protein recently described by Adams et al. (53).

    FOOTNOTES

* This work was supported in part by CNRS, INSERM, and the Association Française de Lutte contre la Mucoviscidose.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence reported in this paper has been submitted to the GenBankTM/EMBL/DDBJ Data Bases with accession number Y16240.

Dagger Recipient of a grant from the Association Claude Bernard.

§ Recipient of a grant from the Délégation Générale pour l'Armement.

To whom correspondence should be addressed. Tel.: 33-4-93-95-77-02; Fax: 33-4-93-95-77-04; E-mail: ipmc{at}cnrs.fr.

1 The abbreviations used are: PCR, polymerase chain reaction; RT, reverse transcription; kb, kilobase(s).

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Epel, D. (1980) Ann. N. Y. Acad. Sci. 339, 74-85[Medline] [Order article via Infotrieve]
  2. Shen, S. S., and Burgart, L. J. (1985) J. Cell Biol. 101, 420-426[Abstract]
  3. LaFleur, G. J., Jr., and Thomas, P. (1991) J. Exp. Zool. 258, 126-136[Medline] [Order article via Infotrieve]
  4. Cameron, I. L., Hunter, K. E., and Cragoe, E., Jr. (1982) Exp. Cell Res. 139, 455-457[Medline] [Order article via Infotrieve]
  5. McCaig, C. D., and Robinson, K. R. (1982) Dev. Biol. 90, 335-339[Medline] [Order article via Infotrieve]
  6. Shi, R., and Borgens, R. B. (1994) Dev. Biol. 165, 105-116[CrossRef][Medline] [Order article via Infotrieve]
  7. Benos, D. J., Biggers, J. D., Balaban, R. S., Mills, J. W., and Overstrom, E. W. (1985) Soc. Gen. Physiol. Ser. 39, 211-235[Medline] [Order article via Infotrieve]
  8. Epel, D. (1990) Cell Differ. Dev. 29, 1-12[CrossRef][Medline] [Order article via Infotrieve]
  9. Kupitz, Y., and Atlas, D. (1993) Science 261, 484-486[Medline] [Order article via Infotrieve]
  10. Robinson, D. H., Bubien, J. K., Smith, P. R., and Benos, D. J. (1991) Dev. Biol. 147, 313-321[Medline] [Order article via Infotrieve]
  11. Biggers, J. D., Bell, J. E., and Benos, D. J. (1988) Am. J. Physiol. 255, C419-C432[Abstract/Free Full Text]
  12. Manejwala, F. M., Cragoe, E. J., and Schultz, R. M. (1989) Dev. Biol. 133, 210-220[Medline] [Order article via Infotrieve]
  13. Powers, R. D., Borland, R. M., and Biggers, J. D. (1977) Nature 270, 603-604[Medline] [Order article via Infotrieve]
  14. Garty, H., and Palmer, L. G. (1997) Physiol. Rev. 77, 359-396[Abstract/Free Full Text]
  15. Driscoll, M., and Chalfie, M. (1991) Nature 349, 588-593[CrossRef][Medline] [Order article via Infotrieve]
  16. Huang, M., and Chalfie, M. (1994) Nature 367, 467-470[CrossRef][Medline] [Order article via Infotrieve]
  17. Liu, J., Schrank, B., and Waterston, R. H. (1996) Science 273, 361-364[Abstract]
  18. Canessa, C. M., Horisberger, J. D., and Rossier, B. C. (1993) Nature 361, 467-470[CrossRef][Medline] [Order article via Infotrieve]
  19. Canessa, C., Schild, L., Buell, G., Thorens, B., Gautschi, I., Horisberger, J. D., and Rossier, B. C. (1994) Nature 367, 463-467[CrossRef][Medline] [Order article via Infotrieve]
  20. Lingueglia, E., Voilley, N., Waldmann, R., Lazdunski, M., and Barbry, P. (1993) FEBS Lett. 318, 95-99[CrossRef][Medline] [Order article via Infotrieve]
  21. Lingueglia, E., Renard, S., Waldmann, R., Voilley, N., Champigny, G., Plass, H., Lazdunski, M., and Barbry, P. (1994) J. Biol. Chem. 269, 13736-13739[Abstract/Free Full Text]
  22. Lingueglia, E., Champigny, G., Lazdunski, M., and Barbry, P. (1995) Nature 378, 730-733[CrossRef][Medline] [Order article via Infotrieve]
  23. Coscoy, S., Lingueglia, E., Lazdunski, M., and Barbry, P. (1998) J. Biol. Chem. 273, 8317-8322[Abstract/Free Full Text]
  24. Waldmann, R., Champigny, G., Bassilana, F., Heurteaux, C., and Lazdunski, M. (1997) Nature 386, 173-177[CrossRef][Medline] [Order article via Infotrieve]
  25. Waldmann, R., Bassilana, F., de Weille, J. R., Champigny, G., Heurteaux, C., and Lazdunski, M. (1997) J. Biol. Chem. 272, 20975-20978[Abstract/Free Full Text]
  26. Bassilana, F., Champigny, G., Waldmann, R., de Weille, J. R., Heurteaux, C., and Lazdunski, M. (1997) J. Biol. Chem. 272, 28819-28822[Abstract/Free Full Text]
  27. Lingueglia, E., de Weille, J. R., Bassilana, F., Heurteaux, C., Sakai, H., Waldmann, R., and Lazdunski, M. (1997) J. Biol. Chem. 272, 29778-29783[Abstract/Free Full Text]
  28. Barbry, P., and Hofman, P. (1997) Am. J. Physiol. 273, G571-G585[Abstract/Free Full Text]
  29. Waldmann, R., Champigny, G., Bassilana, F., Voilley, N., and Lazdunski, M. (1995) J. Biol. Chem. 270, 27411-27414[Abstract/Free Full Text]
  30. Waldmann, R., Champigny, G., and Lazdunski, M. (1995) J. Biol. Chem. 270, 11735-11737[Abstract/Free Full Text]
  31. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159[CrossRef][Medline] [Order article via Infotrieve]
  32. Noselli, S., and Vincent, A. (1992) Gene (Amst.) 118, 273-278[CrossRef][Medline] [Order article via Infotrieve]
  33. Tautz, D., and Pfeifle, C. (1989) Chromosoma (Berl.) 98, 81-85[Medline] [Order article via Infotrieve]
  34. Renard, S., Lingueglia, E., Voilley, N., Lazdunski, M., and Barbry, P. (1994) J. Biol. Chem. 269, 12981-12986[Abstract/Free Full Text]
  35. Lai, C., Hong, K., Kinnell, M., Chalfie, M., and Driscoll, M. (1996) J. Cell Biol. 133, 1071-1081[Abstract]
  36. King, R. C. (1970) Ovarian Development in Drosophila melanogaster, Academic Press, New York
  37. Campos-Ortega, J. A., and Hartenstein, V. (1985) The Embryonic Development of Drosophila melanogaster, Springer-Verlag, Berlin
  38. Weber, W. M., Dannenmaier, B., and Clauss, W. (1993) J. Comp. Physiol. B Biochem. Syst. Environ. Physiol. 163, 153-159[Medline] [Order article via Infotrieve]
  39. Cornell, J. C. (1984) Comp. Biochem. Physiol. A Comp. Physiol. 78, 463-468
  40. García-Añoveros, J., and Corey, D. P. (1997) Annu. Rev. Neurosci. 20, 567-594[CrossRef][Medline] [Order article via Infotrieve]
  41. Darboux, I., Lingueglia, E., Pauron, D., Barbry, P., and Lazdunski, M. (1998) Biochem. Biophys. Res. Commun., in press
  42. Hansson, J. H., Nelson-Williams, C., Suzuki, H., Schild, L., Shimkets, R. A., Lu, Y., Canessa, C. M., Iwasaki, T., Rossier, B. C., and Lifton, R. P. (1995) Nat. Genet. 11, 76-82[Medline] [Order article via Infotrieve]
  43. Jeunemaitre, X., Bassilana, F., Persu, A., Dumont, C., Champigny, G., Lazdunski, M., Corvol, P., and Barbry, P. (1997) J. Hypertens. 15, 1091-1100[CrossRef][Medline] [Order article via Infotrieve]
  44. Shimkets, R. A., Warnock, D. G., Bositis, C. M., Nelson-Williams, C., Hansson, J. H., Schambelan, M., Gill, J. R., Jr., Ulick, S., Milora, R. V., Findling, J. W., Canessa, C. M., Rossier, B. C., and Lifton, R. P. (1994) Cell 79, 407-414[Medline] [Order article via Infotrieve]
  45. Spradling, A. C. (1993) in The Development of Drosophila melanogaster (Bate, M., and Martinez-Arias, A., eds), pp. 1-70, Cold Spring Harbor, Cold Spring Harbor, NY
  46. Woodruff, R. I., and Telfer, W. H. (1980) Nature 286, 84-86[Medline] [Order article via Infotrieve]
  47. Bohrmann, J., and Gutzeit, H. (1987) Development (Camb.) 101, 279-288[Abstract]
  48. Overall, R., and Jaffé, L. F. (1985) Dev. Biol. 108, 102-119[Medline] [Order article via Infotrieve]
  49. Mahowald, A. P., Goralski, T. J., and Caulton, J. H. (1983) Dev. Biol. 98, 437-445[Medline] [Order article via Infotrieve]
  50. Fuller, M. T. (1993) in The Development of Drosophila melanogaster (Bate, M., and Martinez-Arias, A., eds), pp. 71-147, Cold Spring Harbor Press, Cold Spring Harbor, NY
  51. Tates, A. D. (1971) Cytodifferentiation during Spermatogenesis in Drosophila melanogaster: an Electron Microscope Study, J. H. Rasmans, The Hague, The Netherlands
  52. Foe, V. E., Odell, G. M., and Edgar, B. A. (1993) in The Development of Drosophila melanogaster (Bate, M., and Martinez-Arias, A., eds), pp. 149-300, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  53. Adams, C. M., Anderson, M. G., Motto, D. G., Price, M. P., Johnson, W. A., and Welsh, M. J. (1998) J. Cell Biol. 140, 143-152[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.